Don’t miss out on the amazing speakers👇 who will present their latest data on the second day of #PBIC23!
⏰Only three days left to register before the final deadline of 27 October: https://t.co/JcZB7goakx
#Gutbrainaxis#homeostasis
⏳TODAY is your last chance to submit your abstract for #PBIC23! Don't miss this chance to present your research on stage alongside leading scientists or during the poster sessions.
📢Submit here https://t.co/oCkMPmW2jE
🏆Poster Prize by @NeuroCellPress#Gutbrainaxis#homeostasis
⏰Today is your last day to apply for a travel grant for the #PBIC23 conference. Don't miss this chance to visit the beautiful, historical city of Leuven and meet your colleagues.✍Submit your motivation here: https://t.co/3WcbQ8SOP9 #Gutbrainaxis#homeostasis
Congratulations to all! @InflamResCen@bart_lambrecht@VIBLifeSciences@ugent A complement atlas identifies interleukin-6–dependent alternative pathway dysregulation as a key druggable feature of COVID-19 | Science Translational Medicine https://t.co/kcusuhQjXl
Still on the fence about coming to #PBIC23 in the historical city of Leuven? Let OC member Roosmarijn Vandenbroucke of @InflamResCen win you over: https://t.co/R6C3KfZhLG
🧳Travel grant deadline: 25 August
✍Abstract deadline: 12 September
🏋️♀️Core facilities like the @VIBFlowCoreGT are the backbone of scientific progress at @VIBLifeSciences. They provide access to cutting-edge equipment, training opportunities and invaluable knowledge sharing. Together, we're shaping the future of #research!🤝@bart_lambrecht
4 selected talk slots are up for grabs during #Type2Immunity22. Present your latest #immunology results on the plenary stage. Poster presenters have a chance to win the @CellPressNews Poster Prize. Submit your abstract here: https://t.co/Up7OSWcYAl
🔔Abstract deadline: 10 October
Delighted to present this year’s LEO Foundation Award in EMEA to Dr. Esther Hoste from @VIBLifeSciences@ugent for her exceptional contributions to skin research 🥳 Congratulations to Esther – and thank you to our global review panel for your diligence. https://t.co/hr2IzJOW3q
🚨Today is your last chance to apply for a #Type2Immunity22 travel grant. Head over to the conference website to check out the stacked program and join your colleagues in picturesque Ghent:
https://t.co/FfuiM8FZRl #type2immunity#immunity#immunology
👏 Congratulations to Hamida Hammad of the @InflamResCen for winning the ERS Mid-Career Gold Medal Award in #asthma! In Europe, almost 6% of the population suffers from a form of asthma. Thank you @EuroRespSoc for this wonderful recognition.
https://t.co/kRU670XUAB
#Cancer#immunotherapy has become a crucial pillar of anticancer therapy. 19 leading researchers at #ImmunoOnco22 will give new insights into the immune response to tumors and tackle unresolved questions.
⏰Registration Deadline: Thursday 2 June. Read more https://t.co/cc0HC5cj6W
Are you doing immuno-oncology research and want to share the stage with the leading researchers in this field? Then submit your abstract for #ImmunoOnco22 before 7 April: https://t.co/1WE3hz8oT6. Talk & poster pitches slots are up for grabs and the @NatureRevCancer Poster Prize!